SCHEMBL2771003

SCHEMBL2771003

[CH]=C(C)CCC=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492196 1.00
SCHEMBL8700830 0.90 KMT2A (0.73)
SCHEMBL10509053 0.90 KMT2A (0.73)
SCHEMBL8700827 0.90 KMT2A (0.73)
SCHEMBL10509048 0.90 KMT2A (0.73)
SCHEMBL4451127 0.76 KMT2A (0.42)
SCHEMBL4451128 0.76 KMT2A (0.42)
SCHEMBL8388835 0.75
SCHEMBL18955353 0.74 KMT2A (0.46)
SCHEMBL7683654 0.74 KMT2A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2816053-B1 BASE-PROTECTED OLIGONUCLEOTIDE AJINOMOTO KK (JP) 2021-03-24 EP claimed
US-20170226070-A1 METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION CANCER RESEARCH TECHNOLOGIES LLC 2017-08-10 US claimed
WO-2017100514-A1 LIPOPHILIC ANALOGS OF CJ-16264, METHODS OF USE, AND SYNTHESIS THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2017-06-15 WO claimed
US-9371353-B2 Oligonucleotide with protected base AJINOMOTO CO., INC. (JP) 2016-06-21 US claimed
EP-2968346-A2 METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION Cancer Research Technology LLC (US) 2016-01-20 EP claimed
EP-2757905-B1 ACETALS AND KETALS AS FRAGRANCES AND FLAVORS SYMRISE AG (DE) 2015-08-19 EP claimed
US-20150080565-A1 OLIGONUCLEOTIDE WITH PROTECTED BASE AJINOMOTO CO., INC. (JP) 2015-03-19 US claimed
EP-2816053-A1 BASE-PROTECTED OLIGONUCLEOTIDE Ajinomoto Co., Inc. (JP) 2014-12-24 EP claimed
US-8846885-B2 Oligonucleotide with protected base AJINOMOTO CO., INC. (JP) 2014-09-30 US claimed
US-20140275187-A1 METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION CANCER RESEARCH TECHNOLOGY, LLC (US) 2014-09-18 US claimed
US-5932198-A α-amides of L-amino acids as fragrance precursors THE GILLETTE COMPANY (US) 1999-08-03 US claimed
WO-1999030679-A1 α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS THE GILLETTE COMPANY (US) 1999-06-24 WO claimed
WO-1999030680-A1 α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS THE GILLETTE COMPANY (US) 1999-06-24 WO claimed
EP-0829470-A1 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-18 EP claimed
EP-0269739-B1 1,5-DISUBSTITUTED IMIDAZOLES EARTH CHEMICAL CO., LTD. (JP) 1992-08-19 EP claimed
EP-0143461-B1 RHODANINE DERIVATIVE, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Kaken Pharmaceutical Co., Ltd. (JP) 1989-09-06 EP claimed
US-4812473-A 1,5-Disubstituted imidazoles as inhibitors of juvenile hormone EARTH CHEMICAL CO., LTD. (JP) 1989-03-14 US claimed
EP-0269739-A1 1,5-DISUBSTITUTED IMIDAZOLES EARTH CHEMICAL CO., LTD. (JP) 1988-06-08 EP claimed
US-4609736-A ALDOSE REDUCTABLE INHIBITORS KAKEN PHARMACEUTICAL CO., LTD. (JP) 1986-09-02 US claimed
EP-0143461-A2 Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same Kaken Pharmaceutical Co., Ltd. (JP) 1985-06-05 EP claimed